CHENGDU, China, Aug. 10, 2023 /PRNewswire/ — Shanghai Stock Exchange listed company HitGen Inc. (“HitGen”, SSE: 688222.SH) today announced that it has entered into a research service agreement with Nested Therapeutics, Inc. (“Nested”), a biotechnology company pioneering a next-generation…